Table 1.
Linear regression analysis of glucose metabolic markers using histological findings of the liver in patients who underwent metabolic surgery.
| Objective variable | Explanatory variables | b | 95% C.I | p value | ||
|---|---|---|---|---|---|---|
| HOMA-IR | Steatosis | − 0.310 | − 1.270 | 0.639 | 0.5110 | |
| Inflammation | 0.261 | − 0.809 | 1.332 | 0.6275 | ||
| Hepatocyte ballooning | 1.468 | 0.432 | 2.503 | 0.0062 | * | |
| HOMA-b | Steatosis | 5.892 | − 32.404 | 44.188 | 0.7596 | |
| Inflammation | 10.291 | − 32.668 | 53.250 | 0.6340 | ||
| Hepatocyte ballooning | − 3.287 | − 44.817 | 38.244 | 0.8749 | ||
| AUC_BS | Steatosis | − 2233.8 | − 4025.9 | − 441.8 | 0.0154 | * |
| Inflammation | 1050.9 | − 959.4 | 3061.3 | 0.3003 | ||
| Hepatocyte ballooning | 3207.4 | 1264.0 | 5150.9 | 0.0016 | * | |
| AUC_IRI | Steatosis | 517.4 | − 1738.8 | 2773.7 | 0.6485 | |
| Inflammation | 1450.3 | − 1080.7 | 3981.3 | 0.2567 | ||
| Hepatocyte ballooning | 391.4 | − 2055.4 | 2838.3 | 0.7504 | ||
HOMA homeostasis model assessment, IR insulin resistance; AUC area under curve; BS plasma sugar; IRI serum insulin.